Partner Mike Okaty was quoted in an Orlando Business Journal article, “Winter Park biopharma firm Cytocom to go public through merger,” about a merger agreement between Winter Park-based Cytocom Inc. and Cleveland BioLabs Inc., two pharmaceutical companies focused on developing treatments that boost the body’s immune system.
Okaty said health care is an industry where opportunities for mergers and acquisitions persist despite the pandemic. While M&A activity dropped to nearly nothing during the early summer, it has slowly returned in August and September, he said, and is expected to continue growing through the remainder of 2020.
(Subscription required.)
Okaty said health care is an industry where opportunities for mergers and acquisitions persist despite the pandemic. While M&A activity dropped to nearly nothing during the early summer, it has slowly returned in August and September, he said, and is expected to continue growing through the remainder of 2020.
(Subscription required.)
People
Related News
06 February 2025
In the News
Vanessa Miller Assesses Panama Canal Discourse
Foley & Lardner LLP partner Vanessa Miller commented in SupplyChainBrain article, "The Fight for Control of the Panama Canal," lending important context to the recent headlines over the important waterway.
06 February 2025
In the News
Gregory Husisian Weighs in on Suspension of De Minimis Trade Exemption
Foley & Lardner LLP partner Gregory Husisian offered context on President Trump's recent trade actions on China in The Wall Street Journal article, "Why Trump Is Closing a Trade Exemption for China."
04 February 2025
In the News
Andrew Wronski on Tariff Fluidity – 'Keep on top of the issues'
Foley & Lardner LLP partner Andrew Wronski assessed the evolving shift in U.S. trade policy in the Milwaukee Business Journal article, "Trump tariffs won't disappear — so how should Wisconsin businesses prepare?"